Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases. [electronic resource]
- Pathologie-biologie Jun 2014
- 152-5 p. digital
Publication Type: Case Reports; Journal Article
1768-3114
10.1016/j.patbio.2014.01.004 doi
Adolescent Anti-Bacterial Agents--therapeutic use Arthritis, Infectious--drug therapy China--epidemiology Cross Infection--drug therapy Disease Outbreaks--prevention & control Drug Resistance, Multiple, Bacterial--genetics Enterobacter cloacae--drug effects Enterobacteriaceae Infections--drug therapy Female Fluoroquinolones--therapeutic use Fracture Fixation, Internal Humans Infection Control--methods Klebsiella Infections--drug therapy Klebsiella oxytoca--drug effects Levofloxacin--therapeutic use Male Meropenem Middle Aged Osteitis--drug therapy Patient Isolation Protective Clothing Retrospective Studies Surgical Wound Infection--drug therapy Thienamycins--therapeutic use Universal Precautions Wound Infection--drug therapy beta-Lactam Resistance--genetics beta-Lactamases--genetics